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Abstract
Impaired wound healing can lead to scarring, and aesthetical and functional problems. The cytoprotective haem oxygenase (HO) enzymes
degrade haem into iron, biliverdin and carbon monoxide. HO-1 deficient mice suffer from chronic inflammatory stress and delayed cutaneous
wound healing, while corneal wound healing in HO-2 deficient mice is impaired with exorbitant inflammation and absence of HO-1 expression.
This study addresses the role of HO-2 in cutaneous excisional wound healing using HO-2 knockout (KO) mice. Here, we show that HO-2 defi-
ciency also delays cutaneous wound closure compared to WT controls. In addition, we detected reduced collagen deposition and vessel density
in the wounds of HO-2 KO mice compared to WT controls. Surprisingly, wound closure in HO-2 KO mice was accompanied by an inflammatory
response comparable to WT mice. HO-1 induction in HO-2 deficient skin was also similar to WT controls and may explain this protection against
exaggerated cutaneous inflammation but not the delayed wound closure. Proliferation and myofibroblast differentiation were similar in both two
genotypes. Next, we screened for candidate genes to explain the observed delayed wound closure, and detected delayed gene and protein
expression profiles of the chemokine (C-X-C) ligand-11 (CXCL-11) in wounds of HO-2 KO mice. Abnormal regulation of CXCL-11 has been
linked to delayed wound healing and disturbed angiogenesis. However, whether aberrant CXCL-11 expression in HO-2 KO mice is caused by or
is causing delayed wound healing needs to be further investigated.
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Introduction
Cutaneous wound repair occurs in temporally coordinated and
overlapping phases: inflammation, granulation tissue formation and
remodelling [1]. The timely progression of the different phases is
coordinated by cytokines and growth factors, and each phase is
characterized by the presence of specific cell types [2]. Both clinical
and experimental studies have confirmed the importance for a well-
regulated inflammatory resolution for proper wound healing, since
prolonged inflammatory and oxidative stress may cause non-healing,
chronic wounds or excessive scarring [3, 4].
Haem oxygenases (HO) are enzymes that degrade haem into
biliverdin, carbon monoxide and iron. Biliverdin is then converted into
the antioxidant bilirubin by biliverdin reductase. HO-1 is highly induc-
ible by a wide range of stresses, including inflammatory and oxidative
stress, whereas HO-2 is mainly constitutively expressed [5, 6]. The
HO system is important in the resolution of inflammation [7, 8]. The
cytoprotective effects of the stress-induced HO-1 are evident in
various pathological models and settings, whereas the constitutive
#Contributed equally.
*Correspondence to: Frank A. D. T. G. WAGENER, Department of
Orthodontics and Craniofacial Biology, Radboud university medical
center, PO Box 9101, Nijmegen 6500 HB, The Netherlands.
Tel.: +31-243614082
Fax: +31-243540631
E-mail: frank.wagener@radboudumc.nl
ª 2014 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
doi: 10.1111/jcmm.12389
J. Cell. Mol. Med. Vol 18, No 12, 2014 pp. 2488-2498
HO-2 is important for physiological maintenance of the haem pool
[9].
HO-1 deficient humans and mice demonstrate chronic inflam-
matory stress accompanied by increased leucocyte recruitment [10,
11]. Moreover, genetic or pharmacologic ablation of HO-1 expres-
sion and activity in mice results in slower cutaneous wound closure
[12]. Also, HO-2 deficient mice show delayed wound healing and
an exaggerated inflammatory response after corneal epithelial
wounding [13, 14] which was associated with impaired HO-1
induction and function [13]. Notably, HO-2 levels have been
suggested to regulate HO-1 expression and function in a cell and
tissue-specific manner [15], and compensatory HO-1 expression in
HO-2 deficient tissue has been reported [16, 17]. Moreover, genetic
or pharmacological HO-1 induction as well as administration of HO
effector molecules biliverdin/bilirubin down-regulate the inflamma-
tory response and restore wound healing in HO-1 deficient skin
[12, 18] and HO-2 deficient cornea [14, 19]. On the other hand,
HO-1 has pro-angiogenic effects via regulating VEGF synthesis [20,
21]. Wound healing in HO-1 KO mice occurs with reduced neovas-
cularization in the skin [12] whereas exaggerated angiogenesis was
found in HO-2 deficient corneas [19]. Application of biliverdin
ameliorated this pathologic angiogenesis occurring after corneal
wounding in HO-2 KO mice [19].
Because of the described intricate involvement of both HO-1 and
HO-2 in wound healing and regulation of inflammatory responses,
this study focused on exploring the possible role of HO-2 in cutane-
ous wound healing using a full-thickness excisional wound model and
HO-2 KO mice.
Methods and materials
Animals
Homozygote HO-2 KO mice generated by targeted disruption of the
HO-2 gene [22] and WT mice were bred in-house on a mixed 129Sv x
C57BL/6 background. Mice were provided with food and water ad
libitum and maintained on a 12-hr light/dark cycle and specific
pathogen-free conditions. All experiments and protocols were approved
by the institutional Radboud University Nijmegen animal experimentation
committee.
Excisional wound model
Prior to wounding 6–12 weeks old female mice were shaved using an
electrical clipper. The following day four full-thickness wounds were
made on the back including the panniculus carnosus using a sterile
disposable 4-mm biopsy punch (Kai Medical, Seki City, Japan) and
the mice were left uncovered to heal (n = 18/genotype). At day 2
after wounding mice were killed, and the remaining mice (n = 9/geno-
type) were followed until day 7 (n = 9/genotype). For gene transcript
analysis mice were wounded (n = 12/genotype) and killed at day 2
(n = 6/genotype) and day 5 (n = 6/genotype) after wounding.
Punched out tissue at day 0 was collected as control. Wounds were
collected using a disposable 6-mm biopsy punch (Kai Medical) allow-
ing collection of the complete wound together with the surrounding
normal tissue.
Wound size analysis
Wounds were digitally documented on different days with a ruler placed
next to the wounds for size normalization. Wound area was measured
at least twice by a blinded investigator using ImageJ (NIH) v1.44p
software.
Immunohistochemistry
Tissue samples were fixed for 24 hrs in 4% paraformaldehyde and
further processed for routine paraffin embedding. Sections were
deparaffinized using Histosafe and rehydrated using an alcohol range.
Endogenous peroxidase activity was quenched with 3% H2O2 in metha-
nol for 20 min., and immunohistochemical stainings were performed
and photographed as previously described [23]. Photographs were
taken on a Carl Zeiss Imager Z.1 system (Carl Zeiss Microimaging
Gmbh, Jena, Germany). For antibodies and antigen retrievals used, see
Table 1.
Table 1 Antibodies used for immunohistochemistry
Antibody Specificity Dilution Antigen retrieval Source
SPA-895 HO-1 1:800 A Stressgen
OSA-200 HO-2 1:800 A Stressgen
MCA497R F4/80 1:200 A AbD Serotec, Kidlington, UK
2233PCO Collagen IV 1:200 A Euro-Diagnostica, Malmo, Sweden
Sc-34785 CXCL-11 1:100 B Santa Cruz Biotechnology, Santa Cruz, CA, USA
A2547 aSMA 1:600 A Sigma-Aldrich, St. Louis, MO, USA
A: 10 mM citrate buffer 70°C for 10 min, followed by trypsin digestion for 7 min.
B: 10 mM citrate buffer RT, 120 min.
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Semi-quantitative scoring of
immunohistochemical sections
HO-1 and F4/80 immunoreactivity were evaluated as the number of posi-
tive cells (based on the percentage of positive staining) and staining inten-
sity of four sections per animal. Extent was scored as: 0, ≤5%; 1, 6–25%;
2, 26–50%; 3, >50%. Intensity was scored as: 0, weak; 1, moderate; 2,
strong. Intensity was designated as weak when only barely detectable. To
correlate extent and intensity on the staining, a composite score was cal-
culated by multiplying the individual scores of extent by intensity. Scoring
was done three times by a blinded investigator. CXCL-11 immunoreactiv-
ity was evaluated by scoring a single section per animal by two indepen-
dent investigators as previously described [24]. To assess aSMA
immunoreactivity four sections per animal were scored twice as earlier
described [25]. Vascularization was assessed twice on five high-power
fields (HPF; 4009 magnification) on four sections per animal as previously
described [26]. A mean score per animal was used for further analysis.
Collagen deposition
Collagen deposition in AZAN stained wound sections (1–4 sections/
mouse) was determined by image analysis using a macro built in Image
J [27]. The wound area was manually defined before running the macro
using the edges of the panniculus carnosus and epithelium as bound-
aries. Measurements were performed twice, and mean intensity/mm2
per mouse was used for further analysis.
Assessment of mRNA expression by quantitative
real-time PCR
Total RNA was extracted from skin and wound samples by using Trizol
(Invitrogen, Carlsbad, CA, USA) and a RNeasy Mini kit (Qiagen, Hilden,
Germany), and cDNA was produced using the iScript cDNA synthesis kit
(Bio-Rad, Hercules, CA, USA). To screen for differences in gene expression
profiles of wound associated genes in HO-2 KO and WT mice, pooled
cDNAs synthesized from individual wounds of HO-2 KO and WT mice
isolated at day 5 were tested on a Mouse Wound Healing RT2 ProfilerTM
PCR Array according to the manufacturer’s instructions (SABiosciences,
Frederick, MD, USA). Individual cDNAs from all time-points were subse-
quently analysed for genes up- or down-regulated more than twofold using
custom-designed primers (Table 2) and iQ SYBR Green Supermix (Invitro-
gen) in a CFX96 Real-Time PCR system (Bio-Rad). Relative gene expres-
sion values were evaluated using the 2DDCt method using GAPDH as
housekeeping gene [28]. Fold changes were normalized to WT mean day 0.
Western blotting
Protein was extracted from homogenized 4-mm skin biopsies in 100 ll
lysis buffer [1 mM EDTA, 0.5% Triton X-100, Complete protease inhibi-
tor cocktail (Roche, Penzberg, Germany), 100 lM PMSF], and Western
blotting using primary antibodies against HO-1 and HO-2 (SPA-895 and
OSA-200, 1:5000; Stressgen, Victoria, BC, USA) was performed as
previously described [29].
Statistical analysis
Statistical analysis was performed with GraphPad Prism 4.03 software.
Normal data distribution were assessed using the Kolgomorov–Smirnov
test. In case of non-normality, data were transformed. Statistical differences
in qPCR data, wound closure and collagen deposition were determined
using Student’s t-test with Bonferroni-correction in case of multiple testing.
Semi-quantitative scores were analysed with non-parametric Mann–Whitney
test or Kruskall–Wallis test with Dunn’s post hoc test. Collagen deposi-
tion, wound closure and qPCR data are presented as mean  SD. Semi-
quantitative scores are presented as box-and-whisker plots of median
with 10–90 percentiles. P < 0.05 was considered statistically significant.
Results
Delayed cutaneous wound closure in HO-2
deficient mice
Prior to experimental start, we verified that HO-2 KO mice indeed
were devoid of HO-2 mRNA and protein expression (Fig. S1). To
Table 2 Murine primers used for qPCR
Gene Forward primer (50?30) Reverse primer (50?30) Reference
HO-1 CAACATTGAGCTGTTTGAGG TGGTCTTTGTGTTCCTCTGTC –
HO-2 AAGGAAGGGACCAAGGAAG AGTGGTGGCCAGCTTAAATAG –
TNF CTCTTCTCATTCCTGCTTGTG GAATTGTCCATCTGGCATAAC –
CXCL-11 CACGCTGCTCAAGGCTTCCTTATG TGTCGCAGCCGTTACTCGGGT –
Gr-1 TGGACTCTCACAGAAGCAAAG GCAGAGGTCTTCCTTCCAACA –
F4/80 AATCCTGTGAAGATGTGG GAGTGTTGATGCAAATGAAG –
ACTA2 CAGGCATGGATGGCATCAATCAC ACTCTAGCTGTGAAGTCAGTGTCG [51]
GAPDH GGCAAATTCAACGGCACA GTTAGTGGGGTCTCGCTCCTG –
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investigate the role of HO-2 in cutaneous wound closure, full-thickness
wounds were made on the backs of HO-2 KO and WT mice and
monitored in time (Fig. 1). Wound area assessment demonstrated
significantly larger wounds in HO-2 KO mice compared to WT
controls at day 2 [6.9  1.8 mm2 versus 5.1  1.1 mm2 (n = 18/
genotype); P < 0.01], day 5 [4.9  1.6 mm2 versus 2.3  0.4 mm2
(n = 9/genotype); P < 0.001] and day 7 [2.1  0.6 mm2 versus
1.1  0.3 mm2 (n = 9/genotype); P < 0.001] after wounding.
Normal inflammatory response in HO-2 KO mice
after cutaneous wounding
To determine whether delayed cutaneous wound healing in HO-2 KO
mice is because of an exaggerated inflammatory response as
observed after corneal injury, we compared gene expression profiles
of different inflammatory factors and cell markers in skin of HO-2 KO
and WT mice at day 2 and 5 (Fig. 2). The pro-inflammatory cytokine
TNF and the stress-induced enzyme COX-2 demonstrated an injury-
induced increase in transcript levels compared to unwounded skin in
both WT and HO-2 KO mice, however, we did not detect any differ-
ences between the two genotypes at any of the investigated time-
points (Fig. 2A and B). Furthermore, granulocyte marker receptor
antigen-1, Gr-1 and macrophage marker F4/80 both demonstrated an
injury-induced increase in transcript levels compared to unwounded
skin, however, no differences between HO-2 KO and WT mice were
evident (Fig. 2C and D). This was also reflected at the protein level, as
semi-quantitative assessment of F4/80 immunoreactivity in wound
sections demonstrated no significant differences between HO-2 KO
and WT mice at day 2 and day 7 after wounding (Fig. 2E and F).
Injury-induced HO-1 expression in both HO-2 KO
and WT mice
In contrast to HO-2 deficient cornea [13] we detected both HO-1
mRNA transcript and protein in the skin of HO-2 KO mice (Fig. 3).
Similar levels of HO-1 protein were detected in unwounded skin of
HO-2 KO and WT mice (6.9  3.2 and 9.3  6.7, respectively;
Fig. 3A). Also, a comparable injury-induced increase in HO-1
transcript levels was evident in both HO-2 KO and WT mice (Fig. 3B).
Furthermore, injury-induced HO-1 protein expression was detected in
both WT and HO-2 KO skin (Fig. 3C). HO-1 positive cells were present
at high numbers both in the wound area and in the surrounding tissue
at day 2, while at day 7 HO-1 positive cells were predominantly found
in the wound area (Fig. 3C). Semi-quantitative assessment of HO-1
immunoreactivity demonstrated a significant reduction in HO-1
expression at day 7 compared to day 2 in both WT and HO-2 KO
wounds (P < 0.05 for both genotypes), however, no significant
differences between the genotypes were detected (Fig. 3D).
Reduced collagen deposition and lower vessel
density in HO-2 KO wounds
HO-2 KO mice demonstrated no abnormalities compared to WT mice
with respect to the inflammatory phase. We therefore questioned
whether the delayed wound healing was a result of a dysregulated
granulation phase. Assessment of collagen deposition in wound sec-
tions of HO-2 KO and WT mice using an Image J macro demonstrated
a significant lower percentage collagen deposition per area in HO-2
KO wounds compared to WT controls at day 7 after wounding
(8.8  4.2%/mm2 versus 29.8  10.8%/mm2, P < 0.001; Fig. 4A
and B).
Also, we investigated the degree of vascularization in the wound
areas of HO-2 KO and WT mice by semi-quantitative scoring of
wound sections stained for collagen IV, a basement membrane pro-
tein found in the walls of blood vessels [30]. We detected a significant
lower density of vessels per HPF in wound sections of HO-2 KO mice
compared to WT mice at day 7 after wounding (P < 0.05; Fig. 4C and D).
We wondered if the delayed wound healing could be related to a
lower cell proliferation capacity in HO-2 deficient cells, and we there-
fore assessed the mRNA levels of Ki67, a marker of actively cycling
cells [31]. We detected a time-dependent increase in Ki67 mRNA
levels consistent with an increased influx and proliferation of wound
repair associated cells; however, no differences between HO-2 KO
and WT mice were evident at any of the investigated time-points
(Fig. 5A).
A
B
Fig. 1 Slower cutaneous wound closure in HO-2 KO after excisional
wounding. (A) Wound closure in WT (upper panel) and HO-2 KO (lower
panel) mice in time; bar, 5 mm. (B) Wound area (mm2) reduction in
WT (white bars) and HO-2 KO (grey bars) mice in time presented as
mean  SD. **P < 0.01, ***P < 0.001.
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During the granulation phase keratinocytes dominate epitheliza-
tion and (myo)fibroblasts produce ECM such as collagen and
close the wound [32]. We therefore investigated whether the pres-
ence of less (myo)fibroblasts could be an explanation for the
reduced collagen deposition. We detected similar mRNA levels of
ACTA2, the murine counterpart of myofibroblast marker aSMA, at
all examined time-points (Fig. 5B). Moreover, we did not detect
any difference in aSMA protein immunoreactivity level at day 7
after wounding as evaluated by semi-quantitative scoring (Fig. 5C
and D).
A B
D
F
E
C
Fig. 2 HO-2 KO mice demonstrate a normal inflammatory response after wounding. Gene transcript levels of pro-inflammatory proteins (A) TNF and
(B) COX-2 and inflammatory cell markers (C) Gr-1, and (D) F4/80 in WT (white bars) and HO-2 KO (grey bars) mice in time presented as
mean  SD. Controls are tissue biopsies collected at day 0, and data were normalized to WT mean day 0. (E) Box-and-whisker plot with 10–90 per-
centiles of semi-quantitative assessment of F4/80 immunoreactivity in (F). (F) F4/80 immunoreactivity in representative wound sections of WT and
HO-2 KO mice at day 2 and 7 after wounding. Anatomical indications by E, epidermis; D, dermis; H, hypodermis; Pc, panniculus carnosus; bars,
500 lm (upper panel), 100 lm (lower panel).
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Different expression levels of CXCL-11 in WT
and HO-2 KO mice after wounding
HO-1 deficiency is linked to delayed wound healing and impaired
angiogenesis after injury. However, HO-2 deficient skin demon-
strates injury-induced HO-1 expression, and we therefore wondered
which genes could be explanatory for the reduced collagen deposi-
tion and lower vessel density observed in HO-2 KO mice. First we
compared gene expression profiles of pooled cDNAs isolated from
day 5 wound tissue of HO-2 KO and WT mice using a PCR wound
healing array, followed by validation by custom-designed primers
and individual cDNAs. Unexpectedly, after individual validation we
only detected significant differences between HO-2 KO and WT
mice in the expression profile of a single gene out of 84 screened
genes, namely CXCL-11 (Fig. 6A, data not shown). Injury-induced
CXCL-11 gene transcription observed in WT mice was absent in
HO-2 KO mice at day 2 (49.4  25.3 versus 11.5  5.1;
P < 0.05). However, at day 5 after wounding we detected similar
CXCL-11 gene transcription levels in WT and HO-2 KO mice, which
was mainly because of a down-regulation of gene transcription in
WT mice (Fig. 6A). In contrast, immunohistochemical staining and
semi-quantitative scoring of wound tissue isolated from HO-2 KO
and WT mice 7 days after wounding showed a markedly higher
level of CXCL-11 positive cells in the wounds of HO-2 KO mice
compared to WT controls (P = 0.0503; Fig. 6B and C).
Discussion
In this study, we investigated the role of HO-2 in cutaneous
wound closure using HO-2 KO mice and a full-thickness excisional
wound model. High levels of HO-2 in the skin have been
suggested to be a first line of defense against acute injury [33].
Following excisional wounding we observed significantly slower
cutaneous wound closure accompanied by reduced collagen depo-
sition and lower vessel density in HO-2 KO mice compared to WT
controls at day 7. The most pronounced difference in wound heal-
ing rates between HO-2 KO and WT seems to be during the first
days of wound healing.
Cutaneous wounding is followed by haemolysis and free haem
release leading to local oxidative stress and inflammation. HO-1 is
rapidly induced after wounding [34, 35] and promotes inflammatory
resolution by down-regulating inflammatory mediators and attenuat-
ing infiltration of inflammatory cells [36, 37]. Moreover, pharmaco-
logic induction or overexpression of HO-1 accelerates both corneal
and cutaneous wound healing [12, 38]. On the contrary, HO-1
deficiency in man and mice leads to a chronic inflammatory state
[10, 11]. Also, pharmacologic or genetic inhibition of HO-1 slows
down cutaneous wound closure via suppressed re-epithelization and
neovascularization in murine models [12]. In HO-2 KO mice impaired
corneal wound healing is associated with exaggerated inflammation
[13, 39]. We therefore have been suggested that also the delayed
A
C D
B
Fig. 3 HO-2 KO mice induce cutaneous
HO-1 expression after wounding. (A) HO-1
gene transcript levels in WT (white bars)
and HO-2 KO (grey bars) mice in time as
represented as mean  SD. Controls rep-
resent biopsies collected at day 0, and
data were normalized to WT mean day 0.
(B) Western blot (insert) of cutaneous
HO-1 expression in unwounded skin in
WT (white bar) and HO-2 KO (grey bar)
mice. Band intensity was normalized to
housekeeping protein b-actin. Data are
presented as mean  SD. (C) HO-1
immunoreactivity in representative wound
sections of WT and HO-2 KO mice at day
2 and day 7 after wounding. Anatomical
indications by E, epidermis; D, dermis; H,
hypodermis; Pc, panniculus carnosus;
bars, 500 lm (upper panel), 100 lm
(wound, periphery). (D) Semi-quantitative
scores of HO-1 immunoreactivity in (C)
presented as box-and-whisker plot with
10–90 percentiles. *P < 0.05.
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cutaneous wound closure observed in HO-2 KO mice results from an
exaggerated inflammatory response.
Unexpectedly, we did not detect significant differences in the mRNA
or protein expression level of the pro-inflammatory proteins, such as
TNF and COX-2 and markers for granulocytes and macrophages. This
rules out that exaggerated inflammation is the underlying cause of
delayed cutaneous wound closure in HO-2 KO mice. The exaggerated
corneal inflammatory response was associated with impaired HO-1
induction and function [13]. The importance of HO-activity was further
supported by amelioration of corneal inflammatory resolution after
application of biliverdin in HO-2 KO mice [14, 19].
HO-2 can regulate HO-1 induction and function in a tissue and cell
specific manner [15, 17]. Increased HO-1 expression has been
suggested to be a compensatory mechanism in HO-2 deficient lung
and myocardium [16, 40]. We detected similar levels of both HO-1
mRNA and protein expression in unwounded skin and injury-induced
HO-1 up-regulation after wounding of HO-2 KO and WT mice, explain-
ing the normal inflammatory resolution in both genotypes. Cell-type
specific compensatory HO-1 expression likely dampens the inflamma-
tory response after cutaneous wounding, as we observed a normal
inflammatory phenotype in HO-1 expressing skin compared to the
exaggerated inflammatory response in HO-1 deficient corneal tissue
in HO-2 KO mice [13, 39, 41]. Notably, delayed cutaneous wound
closure in HO-1 KO mice is also not accompanied by an uncontrolled
inflammatory response following excisional wounding [12].
We next turned our focus to the granulation phase of cutaneous
wound healing that is dominated by migration, proliferation and
differentiation of fibroblasts, keratinocytes and endothelial cells in the
A
B
C
D
Fig. 4 Reduced collagen deposition and
vessel density in HO-2 KO mice. (A) Rep-
resentative images of AZAN stained
wound sections of WT and HO-2 KO mice
at day 7 after wounding; bar, 200 lm. (B)
Collagen deposition in WT (open circles)
and HO-2 KO (closed circles) mice at day
7 after wounding. (C) Representative
images of collagen IV immunoreactivity, a
common blood vessel marker, in WT and
HO-2 KO mice at day 7 after wounding;
bar, 200 lm. (D) Semi-quantitative scor-
ing of high-power fields of (C). Data are
represented as box-and-whisker plot with
10–90 percentiles. *P < 0.05, ***P < 0.001.
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wound area. Differential expression of HO-1 and HO-2 in keratino-
cytes and fibroblasts has been demonstrated [42]. This difference is
critical for different sensitivities towards UV-induced oxidative stress
[15, 43]. This could also have consequences in a more complex
setting, such as during wound repair. However, we did not observe
any differences between HO-2 KO and WT mice with respect to the
proliferation marker Ki67 or expression of the myofibroblast marker
aSMA during the time course of wound healing.
Angiogenesis is a crucial process for proper wound healing, and
disturbed blood vessel formation leads to delayed wound healing. Pro-
angiogenic properties of HO-1 have been demonstrated [20, 21]. Both
diabetic db/db mice having weaker injury-induced HO-1 expression and
HO-1 deficient mice demonstrate impaired vascularization and delayed
wound closure which could be restored with HO-1 gene transfer [12].
Here, we also observed lower vessel density in the wounds of HO-2 KO
mice despite normal HO-1 expression. This may restrict the blood
supply to the healing tissue and set back wound healing.
To probe the molecular mechanism responsible for the delayed
cutaneous wound closure in HO-2 KO mice, we used a PCR array
containing 84 wound healing associated genes. Surprisingly, we only
detected significant differences between HO-2 KO and WT mice in the
expression profile of a single gene, namely CXCL-11. CXCL-11 is a
versatile cytokine that via interaction with its receptor CXCR3 is
thought to modulate several cell types important during several
phases of cutaneous wound repair [44]. Decreased CXCL-11 or
CXCR3 expression leads to delayed re-epithelization, impaired epider-
mis maturation and is associated with altered angiogenesis [45–48].
CXCL-11 is also an antagonist for C-C chemokine receptor type 5
(CCR5) [49]. CCR5 KO mice have delayed wound closure, impaired
neovascularization and reduced collagen production following exci-
sional wounding [50]. In contrast to WT controls, we did not detect
any injury-induced up-regulation of CXCL-11 mRNA in HO-2 KO mice
at day 2 after wounding. But, surprisingly, more CXCL-11 positive
cells were present in the wounds of HO-2 KO mice compared to WT
controls at day 7 after wounding. These observations imply that there
is a slight delay in the expression of CXCL-11 gene and protein in
HO-2 KO mice compared to WT controls. However, whether this is a
consequence or a causing factor of the delayed cutaneous wound clo-
sure in HO-2 KO mice warrants further investigation. Summarizing,
we demonstrated delayed dermal wound closure, decreased vascular-
ization and reduced collagen deposition in HO-2 KO mice independent
from inflammation and HO-1 expression. These data indicate a tissue-
specific role for HO-2, as HO-2 seems to play a pivotal role in corneal,
but not cutaneous, wound healing. This is directly linked to the
A
C
D
B
Fig. 5Myofibroblast differentiation occurs
in HO-2 KO mice. Ki67 (A) and ACTA2 (B)
gene transcript levels in WT (white bars)
and HO-2 KO (grey bars) mice in time as
represented as mean  SD. Controls rep-
resent biopsies collected at day 0, and
data were normalized to WT mean day 0.
(C) Representative images of aSMA
immunoreactivity in wounds of WT and
HO-2 KO mice at day 7 after wounding;
bar, 200 lm. (D) Semi-quantitative scor-
ing of aSMA in (C) presented as box-and-
whisker plot with 10–90 percentiles.
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regulation of injury-induced HO-1 expression. Furthermore, we report
differences in the expression of the cytokine CXCL-11 between HO-2
KO and WT mice during wound repair. Whether this difference is
causative or caused by the observed delay in cutaneous wound
closure needs to be further investigated.
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Figure S1 Cutaneous HO-2 expression in WT and HO-2 KO mice.
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Fig. 6 Different CXCL-11 expression in HO-2 KO and WT mice after injury. (A) CXCL-11 gene transcript levels in WT (white bars) and HO-2 KO (grey
bars) mice in time presented as mean  SD. Controls represent biopsies collected at day 0, and data were normalized to WT mean day 0. (B)
Semi-quantitative scoring of CXCL-11 immunoreactivity in (C) of WT (white) and HO-2 KO (grey) wounds presented as box-and-whisker plot with
10–90 percentiles. *P < 0.05. (C) Representative images of CXCL-11 immunoreactivity in wound tissue of WT and HO-2 KO mice at day 7 after
wounding; bar, 200 lm. Insert represent magnified boxed area; bar, 70 lm.
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